| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Blossomhill Therapeutics, Inc. Common Stock (BLSM) have been net buyers, picking up 323,900 shares worth roughly $5.2M on balance. In the past 30 days, 4 insiders bought and 0 sold. The tilt toward buying has held up recently.
Schmid John P. (Director) stands out among recent buyers, now holding an estimated $96K in BLSM. Notably, 2 of the recent buyers rank in the top tier of our insider score, which grades how well a person's past trades have anticipated price moves.
BLSM sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.60M | $26.44M | - | |
| 10% | 1.60M | $26.43M | +312.5K | |
| Other | 61.8K | $1.02M | - | |
| Dir | 23.9K | $394.9K | - | |
| Other | 22.7K | $374.8K | +4.7K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Schmid John P.80 | Director | Buy | 6,000 | $16.00 | $96,000.00 | New | |
| Aug 10, 2026 | Chen Bihua56 | Director, 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +9.5% | |
| Aug 10, 2026 | Liptak Vincent Paul | General Counsel | Buy | 4,700 | $15.89 | $74,700.00 | +2.2% | |
| Aug 10, 2026 | Keyes Jason A72 | Chief Financial Officer | Buy | 700 | $16.00 | $11,200.00 | New |